Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 29,535 Shares of Stock

Key Points

• Insider Robert Scavo sold 29,535 shares of Alignment Healthcare for approximately $484,669.35, reducing his ownership by 4.91%.
• Alignment Healthcare's stock has shown volatility, with a 12-month low of $8.82 and a high of $21.06, while trading at $16.45 recently.
• In its latest earnings report, Alignment Healthcare saw a 49% year-over-year increase in revenue and beat earnings estimates, reporting $1.02 billion in revenue.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Robert L. Scavo sold 29,535 shares of the company's stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $484,669.35. Following the completion of the transaction, the insider owned 572,555 shares of the company's stock, valued at approximately $9,395,627.55. The trade was a 4.91% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Alignment Healthcare Stock Up 1.7%

Shares of Alignment Healthcare stock traded up $0.28 during trading hours on Monday, hitting $16.32. The company had a trading volume of 4,336,879 shares, compared to its average volume of 3,638,717. The company's 50-day moving average is $14.47 and its two-hundred day moving average is $15.54. Alignment Healthcare, Inc. has a twelve month low of $9.15 and a twelve month high of $21.06. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. The company has a market cap of $3.23 billion, a P/E ratio of -58.28 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company's revenue for the quarter was up 49.0% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Trading of Alignment Healthcare

Several hedge funds have recently made changes to their positions in ALHC. MCF Advisors LLC lifted its stake in shares of Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after acquiring an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare in the 1st quarter worth $42,000. SBI Securities Co. Ltd. lifted its stake in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock worth $42,000 after acquiring an additional 2,970 shares during the period. KBC Group NV acquired a new stake in shares of Alignment Healthcare in the 2nd quarter worth $44,000. Finally, Signaturefd LLC lifted its stake in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company's stock worth $53,000 after acquiring an additional 2,215 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on ALHC shares. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a research note on Monday, August 25th. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Finally, Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Alignment Healthcare has an average rating of "Moderate Buy" and a consensus target price of $18.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.